Skip to main content

Find Clinical Trials

Home
Conditions
Influenza, Human

Clinical trial condition

Influenza, Human

Explore clinical trials studying Influenza, Human. Study availability and eligibility vary by location and protocol.

1,849 public trials 83 recruiting studies

Refine in advanced search Browse all conditions

Influenza, Human trial results

Completed

A Study of Modified mRNA Vaccines in Healthy Adults

NCT05397223

Conditions: COVID-19, Coronaviridae Infections, Coronavirus Infections, +18 more
Locations: CenExel Hollywood, Florida, United States

Meridian Clinical Research Savannah, Georgia, United States

Meridian Clinical Research Sioux City, Iowa, United States

Johnson County Clinical Trials Lenexa, Kansas, United States

View Trial Details

Completed

A Study to Find the Dose and Assess the Immune Response and Safety of a Vaccine Against Influenza in Healthy Younger and Older Adults

NCT06431607

Conditions: Infections, Influenza, Human, Orthomyxoviridae Infections, +4 more
Locations: GSK Investigational Site Hialeah, Florida, United States

GSK Investigational Site Miami, Florida, United States

GSK Investigational Site Miami, Florida, United States

GSK Investigational Site Chicago, Illinois, United States

View all 18 locations

View Trial Details

Completed

A Study on the Safety, Reactogenicity and Immune Response of a Vaccine Against Influenza in Healthy Younger and Older Adults

NCT05446740

Conditions: Infections, Influenza, Human, Orthomyxoviridae Infections, +4 more
Locations: GSK Investigational Site Edegem, Belgium

GSK Investigational Site Ghent, Belgium

GSK Investigational Site Halifax, Nova Scotia, Canada

GSK Investigational Site Sherbrooke, Quebec, Canada

View Trial Details

Completed

Repeated Cross Sectional Surveillance Study To Determine the Influenza Vaccination Rates in German Participants

NCT06800885

Conditions: Infections, Influenza Immunization, Influenza, Human, +5 more
Locations: Germany

View Trial Details

Completed

MxA-Guided Antiviral Treatment in Respiratory Viral Infections

NCT06668025

Conditions: Infections, Influenza, Influenza, Human, +7 more
Locations: China-Japan Friendship hospital Beijing, Beijing Municipality, China

View Trial Details

Completed

A Study to Learn How Safe, Tolerable and Capable of Producing an Immune Response is, a Modified RNA Vaccine Against Pandemic Influenza

NCT06179446

Conditions: Grippe, Infections, Influenza, +7 more
Locations: Pfizer Clinical Research Unit - New Haven New Haven, Connecticut, United States

Research Centers of America Hollywood, Florida, United States

NYU Langone Health New York, United States

View Trial Details

Completed

Live Attenuated Influenza Vaccine as a Nasal Model for Influenza Infection

NCT04164212

Conditions: Infections, Influenza, Influenza, Human, +5 more
Locations: UAB Lung Health Center Birmingham, Alabama, United States

View Trial Details

Completed

Lower Respiratory Tract Infections Managed in Primary Care in France

NCT07416266

Conditions: Acute Bronchitis, Acute Exacerbation Chronic Obstructive Pulmonary Disease, Bronchial Diseases, +16 more
Locations: Not specified

View Trial Details

Completed

Characterizing Late-season Influenza Vaccine Responses to Compare the 2023 and 2024 Vaccine Formulations

NCT06567860

Conditions: Infections, Influenza A, Influenza, Human, +5 more
Locations: La Jolla Institute for Immunology La Jolla, California, United States

View Trial Details

Completed

A Study to Find and Confirm the Dose and Assess Safety, Reactogenicity and Immune Response of a Vaccine Against Pandemic H5N1 Influenza Virus in Healthy Younger and Older Adults

NCT06382311

Conditions: Animal Diseases, Bird Diseases, Infections, +7 more
Locations: GSK Investigational Site Anniston, Alabama, United States

GSK Investigational Site Little Rock, Arkansas, United States

GSK Investigational Site Fort Collins, Colorado, United States

GSK Investigational Site Fort Myers, Florida, United States

View all 21 locations

View Trial Details